AHA Scientific Sessions 2025 Abstract
Inclisiran Nonresponse with PCSK9 Variant and Successful LDL-C Lowering with Evinacumab in a Patient with Homozygous Familial Hypercholesterolemia
The paper
Methodist Dallas Medical Center; Dallas VA Medical Center
AHA Scientific Sessions 2025 Abstract, 3 Nov 2025
Presented at AHA Scientific Sessions 2025, abstract 4338231


